Haemophilia: Vol 16, No 3

I consent to Wiley Online Library’s Terms of Use and processing of my personal data as disclosed in Wiley’s Privacy Policy.I consent to my personal information being transferred outside of the People’s Republic of China as laid out in Wiley’s Privacy Policy.*(Optional) I consent to special offers, newsletter & promotions from Wiley. See Privacy Policy for more details.

Tools

Submit an article

Haemophilia

Journal list menu

Tools

Follow journal

Haemophilia: Volume 16, Issue 3

Download PDFs

Review Articles

The optimal mode of delivery for the haemophilia carrier expecting an affected infant is vaginal delivery

The optimal mode of delivery for the haemophilia carrier expecting an affected infant is caesarean delivery

Commentary

What is the optimal mode of delivery for the haemophilia carrier expecting an affected infant-vaginal delivery or caesarean delivery?

Malignancy in patients with haemophilia: a review of the literature

Original Articles

Clinical haemophilia

Mortality and causes of death in Italian persons with haemophilia, 1990–2007

Patient resources in the therapeutic education of haemophiliacs in France: their skills and roles as defined by consensus of a working group

Alarmingly high prevalence of obesity in haemophilia in the state of Mississippi

Paediatrics

Safety and efficacy of investigator-prescribed BeneFIX® prophylaxis in children less than 6 years of age with severe haemophilia B

Inhibitors

Polymorphisms in genes involved in autoimmune disease and the risk of FVIII inhibitor development in Italian patients with haemophilia A

Orthopaedics

Long-term evaluation of chromosomal breakages after radioisotope synovectomy for treatment of target joints in patients with haemophilia

Utility of the Haemophilia Joint Health Score in study of episodically treated boys with severe haemophilia A and B in Lithuania

The value of early treatment in patients with haemophilia and inhibitors

Physical activity for prevention of osteoporosis in patients with severe haemophilia on long-term prophylaxis

Hepatitis C

Efficacy and safety of pegylated interferon alpha-2a therapy for chronic hepatitis C in HIV-infected patients with haemophilia

Laboratory science

Commentary

The use of animal pharmacokinetic data to evaluate human dosing

Thrombin generation and fibrinolysis in anti-factor IX treated blood and plasma spiked with factor VIII inhibitor bypassing activity or recombinant factor VIIa

Correction(s) for this article

Corrigendum

Comparison of kaolin and tissue factor activated thromboelastography in haemophilia

Genetics

Interlocus non-random association of multiallelic polymorphisms spanning the coagulation factor VIII gene on human chromosome distalmost Xq28

Genetic analysis of haemophilia A in Taiwan

Letters to the Editors

Maintenance of treatment logs by haemophilia patients

Risk-sharing approach for managing factor VIIa reimbursement in haemophilia patients with inhibitors

Ten novel factor VIII (F8C) mutations in eighteen haemophilia A families detected in Singapore

A novel point mutation in severe haemophilia A: a further proof of genotype-phenotype correlation

Clinical use of Haemate-P in inherited von Willebrand’s disease: a patient with type 3 VWD and recurrent menometrorrhagia

Osteoid osteoma in a child with severe von Willebrand disease

Management of patients with factor V deficiency: open issues from the challenging history of a woman with anaphylactic transfusion reactions

Characterization of the genetic basis of FXI deficiency in two Turkish patients

Corrigendum

Corrigendum

This article corrects the following:

Thrombin generation and fibrinolysis in anti-factor IX treated blood and plasma spiked with factor VIII inhibitor bypassing activity or recombinant factor VIIa

Sign up for email alerts

Tools

More from this journal

Safety and efficacy of investigator-prescribed BeneFIX^® prophylaxis in children less than 6 years of age with severe haemophilia B